HomeWebinarsKnockdown, Knockout, Validate: Lentivirus delivers payload in vitro and in vivo for CRISPR, RNAI, and ORF applications

Knockdown, Knockout, Validate: Lentivirus delivers payload in vitro and in vivo for CRISPR, RNAI, and ORF applications

Webinar

What Does it Cover?

Whether you are looking to knockout, knockdown, or overexpress genes, lentiviral transduction is the superior mechanism for delivering genetic cargo into hard to transfect cells and in vivo systems. Lentivirus is a perfect tool for screening applications since the delivered genetic material is constitutively expressed by the cells long-term. We will discuss the flexibility of our expert manufacturing group and present examples of applications suitable with lentivirus.

During this webinar, we dispel the preconceived misconception that lentivirus is risky or cumbersome to use. As a trusted lentiviral manufacturer, we will share our best practices for handling lentivirus and the simple steps that set you up for success.

What Will You Learn?

  • Lentivirus biosafety features and best handling practices
  • Flexible customization options to fit your needs
  • Techniques to incorporate lentivirus into your gene studies
  • Insight from a leading Lenti manufacturing expert

Who Should Attend?

  • Any researcher who is interested in how lentivirus could improve their CRISPR, RNAi, or ORF expression levels
  • Researchers working with challenging cell lines
  • Any researcher new to working with CRISPR, RNAi, or ORF technologies that want to understand the delivery options available

Speaker

Christy Hoffmann

Merck

Genome Editing Tools Product Management

Christy Hoffmann earned her BS in Biology from Truman State University and has gained over 18 years of industrial biotechnology experience in high throughput cell culture, cloning, and lentivirus manufacturing. She joined us in 2005 as one of the first members of MISSION® Operations Production, a team responsible for developing and manufacturing the TRC shRNA products. She then advanced to Supervisor of Lentiviral manufacturing, a group responsible for launching lentiviral shRNA, ORF, CRISPR, and Sanger QuickPick™ KO research tools. In her present role, Christy is a Market Segment Manager for Genome Editing Tools where she manages marketing and product development aspects of CRISPR, RNAi, and ORF technologies.

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.